Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?

Medicina (Kaunas) · 2024 · PMC11728110 · PMID 39768911

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Other lung parameters did not reach statistical significance compared to the placebo group, but this opens the way for the preferred treatment with GLP-1 receptor agonists in this clinical setting [ 36 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.